Healthcare solutions provider Qyral announced it is expanding operations into Puerto Rico. In addition to the company’s weight management system, prescription products Semaglutide and Tirzepatide will be available to local residents through the company’s platform.
This international expansion is expected to help the company “broaden its footprint in the wellness industry and connect with a new audience eager for advanced weight management solutions.”
“Our arrival in Puerto Rico represents an exciting milestone for Qyral,” said Hanieh Sigari, Qyral CEO and Founder. “We are thrilled to help empower individuals across Puerto Rico to transform their lives with our personalized services.”
